Down-Regulation of the Expression and Function of the Transporter Associated with Antigen Processing in Murine Tumor Cell Lines Expressing IL-10

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3195-3202

  Salazar Onfray, Flavio ^a   Charo, Jehad ^a   Petersson, Max ^a   Freland, Sofia ^a   Noffz, Gabriele ^c   Qin, Zhihai ^c   Blankenstein, Thomas ^c   Ljunggren, Hans Gustaf ^a   Kiessling, Rolf ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; H2 ANTIGEN; INTERLEUKIN 10; PEPTIDE; TAP1 PROTEIN, HUMAN; TAP1 PROTEIN, MOUSE; TAP2 PROTEIN, HUMAN; TAP2 PROTEIN, MOUSE;

ANIMAL; ANTIGEN PRESENTATION; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOMA; METABOLISM; MOUSE; NATURAL KILLER CELL; PHYSIOLOGY; PLASMACYTOMA; PROTEIN PROCESSING; SARCOMA; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; DOWN-REGULATION; ENDOPLASMIC RETICULUM; H-2 ANTIGENS; IMMUNITY, NATURAL; INTERLEUKIN-10; KILLER CELLS, NATURAL; LYMPHOMA; MAST-CELL SARCOMA; MICE; MICE, INBRED C57BL; PEPTIDES; PLASMACYTOMA; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031252309     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Townsend, A., and H. Bodmer. 1989. Antigen recognition by class I restricted T lymphocytes. Annu. Rev. Immunol. 7:601.
2. Yewdell, J. W., and J. R. Bennink. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T-lymphocytes. Adv. Immunol. 52:1.
3. Goldberg, A. L., and K. L. Rock. 1992. Proteolysis, proteasomes and antigen presentation. Nature 357:375.
4. Townsend, A., and J. Trowsdale. 1993. The transporters associated with antigen presentation. Semin. Cell. Biol. 4:53.
5. Ljunggren, H.-G., N. J. Stam, C. Öhlén, J. J. Neefjes, P. Höglund, M.-T Heemels, J. Bastin, T. N. M. Schumacher, A. Townsend, K. Kärre, and H. L. Ploegh. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476.
6. Ortmann, B., M. J. Androlewicz, and P. Cresswell. 1994. MHC class I/β2 microglobulin complexes associate with TAP transporters before peptide binding. Nature 368:864.
7. Suh, W.-K., M. F. Cohen-Doyle, K. Fruh, K. Wang, P. A. Peterson, and D. B. Williams. 1994. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264:1322.
8. 2-microglobulin observed in cells with increased sensitivity to NK lysis. J. Immunol. 142:2911.
9. Townsend, A., C. Öhlén, J. Bastin, H. G. Ljunggren, L. Foster, and K. Kärre. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443.
10. Restifo, N. P., F. Esquivel, Y. Kawakami, J. W. Yewdell, J. J. Mulé, S. A. Rosenberg, and J. R. Bennink. 1993. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:265.
11. Sugita, K., J.-I. Miyazaki, E. Appella, and K. Ozato. 1987. Interferons increase transcription of a major histocompatibility class I gene via a 5′ interferon consensus sequence. Mol. Cell. Biol. 7:2625.
12. + T cells against the wild type tumor: correlation with antigen presentation capability. J. Exp. Med. 175:1423.
13. Brown, M. G., J. Driscoll, and J. J. Monaco. 1991. Structural and serological similarity of MHC-linked LMP and proteosome (multicatalytic proteinase) complexes. Nature 353:355.
14. Matsuda, M., F. Salazar, M. Petersson, G. Masucci, J. Hansson, P. Pisa, Q.-J Zhang, M. G. Masucci, and R. Kiessling. 1994. Interleukin-10 pre-treatment protects target cells from tumorand allo-specific cytotoxic T-cells and down-regulates HLA class I expression. J. Exp. Med. 180:2371.
15. Salazar-Onfray, F., M. Petersson, L. Franksson, M. Matsuda, T. Blankenstein, K. Kärre, and R. Kiessling. 1995. IL-10 converts mouse lymphoma cells to a CTLresistant, NK sensitive phenotype with low but peptide-inducible MHC class I expression. J. Immunol. 154:6291.
16. Fiorentino, D. F., A. Zlotnic, P. Viera, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:1444.
17. Taga, K. G., and G. Tosato. 1992. IL-10 inhibit T cell proliferation and IL-2 production. J. Immunol. 148:1143.
18. Groux, H., M. Bigler, J. E. de Vries, and M.-G. Roncarolo. 1996. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T-cclls. J. Exp. Med. 184:19.
19. de Waal-Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991 IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II MHC expression. J. Exp. Med. 174:915.
20. Ralph, P., and I. Nakoinz. 1974. Lipopolysaccharides inhibit lymphosarcoma cells of bone marrow origin. Nature 249:49.
21. Kärre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-delicienl lymphoma variants suggest alternative immune defence strategy. Nature 319:675.
22. Richter, G., S. Kruger-Krasagakes, G. Hein, C. Huls, E. Schmitt, T. Diamantstein, and T. Blankenstein. 1993. Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res. 53:4134.
23. Blankenstein, T., Z. H. Qin, K. Uberla, W. Muller, H. Rosen, H.-D. Volk, and T. Diamantstein. 1991. Tumor suppression after tumor cell-targeted tumor necrosis factor α gene transfer. J. Exp. Med. 171:1047.
24. Lupton, S. D., L. L. Brunton, V. A. Kalberg, and R. W Overell. 1991. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell. Biol. 11:3374.
25. Ljunggren, H. G., M. Oudshoorn-Snoek, M. G. Masucci, and H. L. Ploegh. 1990. High-resolution one-dimensional isoeleclric focusing of mouse MHC class I antigens: identification of natural and experimentally induced class I antigens. Immunogenetics 32:440.
26. Shepherd J. C., T. N. M. Schummacher, P. G. Ashton-Rickardt, S. Imaeda, H. L. Ploegh, C. A. Janeway, and S. Tonegawa. 1993. TAP1 dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74:577.
27. Neefjes, J. J., F. Momburg, and G. J. Hämmerling. 1993. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261:769.
28. Lattime, E. C. M. J. Mastrangelo, and D. Berd. 1994. Human metastatic melanoma lesions and cell lines express mRNA for IL-10. Proc. Am. Assoc. Cancer Res. 35:489.
29. Chen, Q., V. Daniel, D. W. Maher, and P. Hersey. 1994. Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int. J. Cancer 56:755.
30. Gotlieb, W. H., J. S. Abrams, J. M. Watson, T. J. Velu, J. S. Berek, and O. Martínez-Maza. 1992. Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine 4:385.
31. Gastl, G. A., J. S. Abrams, D. M. Nanus, R. Osterkamp, J. Silver, F. Liu, M. Chen, A. P. Albino, and N. H. J. Bander. 1993. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer 55:96.
32. Huang, M., J. Wang, P. Lee, S. Sharma, J. T. Mao, H. Meissner, K. Uyemura, R. Modlin, J. Wollman, and S. M. Dubinett. 1995. Human non-small lung cancer cells express a type 2 cytokine pattern. Cancer Res. 55:3847.
33. Benjamin, D., T. Knobloch, and M. Dayton. 1992. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphomas constitutively secrete large quantities of interleukin-10. Blood 80:1289.
34. Nakagomi, H., R. Dolcetti, M. T. Bejarano, P. Pisa, R. Kiessling, and M. G. Masucci. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 in Burkitt lymphoma lines. Int. J. Cancer 57:240.
35. Pisa, P., E. Halapi, E. Pisa, E. K. Gerdin, C. Hising, A. Bucht, B. Gerdin, and R. Kiessling. 1992. Selective expression of interleukin 10, interferon-γ and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc. Natl. Acad. Sci. USA 89:7708.
36. Nakagomi, H., P. Pisa, E. K. Pisa, Y. Yamamoto, E. Halapi, K. Backlin, C. Juhlin, and R. Kiessling. 1995. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int. J. Cancer 63:366.
37. Kim, J., R. L. Modlin, R. L. Moy, S. M. Dubinett, T. McHugh, B. J. Nickoloff, and K. Uyemura 1995. IL-10 production in cutaneous basal and squamous cell carcinomas. J. Immunol. 155:2240.
38. Lattime, E. C., M. J. Mastrangelo, O. Bagasra, W. Li, and D. Berd. 1995. Expression of cytokine mRNA in human melanoma tissues. Cancer Immunol. Immunother. 41:151.
39. Maxwell, E., I. King, J. J. Cantino, J. Chen, F. Garaud, and L. M. Zheng. 1994. In vivo effects of hIL-10 on the growth of various tumors. Proc. Am. Assoc. Cancer Res. 35:480.
40. Giovarelli, M., P. Musiani, A. Modesti, P. Dellabona, G. Casorati, A. Allione, M. Consalvo, F. Cavallo, F. di Piero, C. De Giovanni, T. Musso, and G. Forni. 1995. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances anti-tumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J. Immunol. 155:3112.
41. Zheng, L. M, D. M. Ojcius, F. Garaud, C. Roth, E. Maxwell, Z. Li, H. Rong, J. Cheng, X. Y. Wang, J. J Cantino, and I. King. 1996. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J. Exp. Med. 184: 579.
42. Sugita, K., J.-I. Miyazaki, E. Appella, and K. Ozato. 1987. Interferons increase transcription of a major histocompatibility class I gene via a 5′ interferon consensus sequence. Mol. Cell. Biol. 7:2625.
43. Restifo, N. P., F. Esquivel, Y. Kawakami, J. W. Yewdell, J. J. Mulé, S. A. Rosenberg, and J. R. Bennink. 1993. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:265.
44. + T cells against the wild type tumor: correlation with antigen presentation capability. J. Exp. Med. 175:1423.
45. Lin, Y., G. Proud, R. M. Taylor, and J. A. Kirby. 1993. Renal allograft rejection: protection of renal epithelium from natural killer cells by cytokine-induced up-regulation of class I major histocompatibility antigens. Immunology 79:290.
46. Welsh, R. M., K. Kärre, M. Hansson, L. A. Kunkel, and R. W. Kiessling. 1981. Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells. J. Immunol. 126:219.
47. Trinchieri, G., and D. Santoli. 1978. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus transformed cells: enhancement of natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J. Exp. Med. 147:1314.
48. Kaklamanis, L., A. Townsend, I. A. Doussis-Anagnostopoulou, N. Mortensen, A. L. Harris, and K. C. Gatter. 1994. Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am. J. Pathol. 145:505.
49. Cromme, F. V., J. Airey, M. T. Heemels, H. L. Ploegh, and J. M. M. Walboomers. 1994. Loss of transporter protein, encoded by the TAP-2 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. Exp. Med. 179:335.
50. Seliger, B., A. Höhne, A. Kuth, H. Bernhard, T. Meyer, R. Tampe, F. Momburg, and C. Huber. 1996. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression. Cancer Res. 56: 1756.
51. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411.
52. Früh, K., K. Ahn, H. Djaballah, P. Sempé, P. M. van Endert, R. Tampé, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415.
53. Rotem-Yehudar, R., S. Winograd, S. Sela, J. E. Coligan, and R. Ehrlich. 1994. Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12. J. Exp. Med. 180:477.
54. Rotem-Yehudar, R., M. Groettrup, A. Soza, P. M. Kloetzel, and R. Ehrlich. 1996. Lmp-associated proteolytic activities and TAP-dependent peptide transport for class I MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12. J. Exp. Med. 183:499.
55. Bacchetta, R., M. Bigler, J.-L. Touraine, R. Parkman, P. A. Tovo, J. Abrams, R. de Waal Malefyt, J. E. de Vries, and M. G. Roncarolo. 1994. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179: 493.